A quality-adjusted life year (QALY) is used as a generic measure of how disease impacts the quality and quantity of your life. A QALY ranges from 1 (perfect health) to 0 (death).

Pricing a new drug is not an easy task, Gilead who is producing remdesivir is no stranger to pricing controversy, the release of Solvaldi, their drug to cure Hepatitis C, had a list price of $84,000 for a full treatment course.